Upcoming EventsMar27MonMar28Tueall-day 4th African Islamic Finance summit @ Hyatt Regency4th African Islamic Finance summit @ Hyatt RegencyMar 28 – Mar 29 all-day4th African Islamic Finance summit read moreShareApr4TueApr6Thuall-day Global Forum on EPC Project Mana...Global Forum on EPC Project Mana...Apr 6 – Apr 7 all-day6th – 7th April, Berlin Conference overview EPC Project Management is the “Heart” of internal and external Operational division of Power and O&G industries with its own Scale and Complexity. With the current challenges and the drop in the oil price, Contract … Continue reading →Apr17Monall-day Future Play & Playspaces MENA 2017 @ DubaiFuture Play & Playspaces MENA 2017 @ DubaiApr 17 – Apr 18 all-dayFuture Play & Playspaces MENA has been specifically created for those developing, designing, building and equipping indoor and outdoor play facilities across the MENA region. It’s an event dedicated to showcasing the growing business opportunities in this rapidly expanding sector. … Continue reading →Apr24Monall-day 3rd Congo International Hydrocar... @ The Palais des Congres, Brazzaville3rd Congo International Hydrocar... @ The Palais des Congres, BrazzavilleApr 24 – Apr 26 all-dayOn behalf of the Ministry of Hydrocarbons, Republic of Congo & AME Trade Ltd, we are delighted to welcome you to the Republic of Congo’s Third International Oil and Gas Conference and Exhibition (CIEHC-3). CIEHC will take place at the … Continue reading →
Tag Archives: Pharmaceuticals
Mylan Launches Innovative Portfolio of Antiretroviral Products for Treatment of HIV/AIDS in South Africa
JOHANNESBURG and PITTSBURGH /PRNewswire/ — Mylan Inc. (Nasdaq: MYL), one of the world’s leading generic and specialty pharmaceutical companies, today announced that its subsidiary in South Africa, Mylan (Proprietary) Limited, has launched a comprehensive portfolio of antiretroviral (ARV) products. South Africa has the world’s largest HIV/AIDS population, with approximately 5.6 million1 people living with the disease and an estimated 1.7 million2 people receiving treatment.
New Market Research Report Added in MarketResearchReports.Biz Database Advanced Wound Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
Albany, NY, February, 2013 –(PR.com)– Advanced Wound Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
GlobalDatas new report, Advanced Wound Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 provides key market data on the Advanced Wound Management market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within seven market categories Foams, Hydrocolloids, Alginates, Semi-Permeable Films, Hydrofibres, Hydrogels, Collagens and Wound Contact Layers. The report also provides company shares and distribution shares data for the overall Advanced Wound Management market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.
TechNavio’s analysts forecast the Global Non-small Cell Lung Cancer market to grow at a CAGR of 2.77 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Ophthalmic Drugs market has also been witnessing the trend of emergence of personalized medicines. However, the increasing use of complementary and alternative medicine could pose a challenge to the growth of this market.
London, United Kingdom, January, 2013 –(PR.com)– TechNavio launched its report, Global Non-small Cell Lung Cancer Drugs Market 2012-2016, based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the significant trends impacting this market.
Standard Bank Group has been ranked 98 on the Global 100 Most Sustainable Corporations in the World list and is the only African company on the list. It’s also one of only nine banks listed. Its official ranking was announced at the World Economic Forum in Davos, Switzerland.
Mylan Selected As One of the Leading Suppliers to the South African National Department of Health 2013/2014 Antiretroviral Tender
JOHANNESBURG and PITTSBURGH, Nov. 29, 2012 /PRNewswire/ — Mylan Inc. (Nasdaq: MYL) announced today that its subsidiary in India, Mylan Laboratories Ltd., a leading manufacturer of antiretroviral (ARV) drugs, has been selected, through its South African-based subsidiary Mylan (Proprietary) Limited (Mylan Limited), as one of the leading suppliers of ARV drugs to the South African National Department of Health for the tender period January 1, 2013 to December 31, 2014.
13-15 SEPTEMBER 2012
Oncobiologics and Boston Oncology Team Up to Deliver Biosimilar Therapies for Cancer and Immune Disease to Middle East and North African Markets
CRANBURY, N.J. and CAMBRIDGE, Mass., Nov. 6, 2012 /PRNewswire/ — Oncobiologics, Inc. and Boston Oncology, LLC today announced a strategic partnership that will allow Boston Oncology to license, manufacture, and commercialize four of Oncobiologics’ biosimilar therapies for cancer and immunological disease in the Middle East and North African (MENA) regions.